Pay in 4 interest-free payments of $7.43 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The driver may be systemic or involve a different pathway, including mast-cell activation
Right now, many people, especially those from marginalized populations, cant access GLP-1 medications, for financial or other reasons
Choosing the right one depends on your goals
pylori eradication, expanding GI treatment scope CG MedTech completes smart office, expands implant production capacity Daewoong, FMI invest in General Proximity to advance induced-proximity drugs Dong-A University Hospital rolls out regions largest AI smart ward with Daewoong Daewoong, Puzzle AI partner to launch AI medical record platform CL Note Daewoongs Fexuclue wins Indonesia nod, expands into Southeast Asia P-CAB market MetaVias obesity drug candidate DA-1726 to be presented at European liver meeting Daewoong takes over US anti-aging platform in $239 mil-linked deal Beyond weight loss: Korean drugmakers to showcase obesity innovation at ADA 2026 Kim Ji-hye [email protected]
This is a normal part of the titration schedule
The approval is backed by results from the Phase IIb/III QUASAR study, in which participants given 200 mg of Tremfya every four weeks saw clinical remission at 44 weeks, compared with 19% in the placebo group
US$ 26.64
US$ 28.60
US$ 29.26
